Shoshana Rath

Shoshana Rath

Auto-generated profile, based on publicly available information

Shoshana Rath

Department of Endocrinology Princess Margaret Hospital , Child and Adolescent Services & School of Pediatrics and Child Health, University of Western Australia Perth Australia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
SRShoshana R. Rath
Shoshana R. Rath
ABAnthony Bartley
Anthony Bartley
ACAdrian Charles
Adrian Charles
NPNeil Powers
Neil Powers
GBGareth Baynam
Gareth Baynam
CCCatherine S. Y. Choong
Catherine S. Y. Choong
Disclosure Summary: The authors have nothing to disclose.

5 April 2013 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
SRShoshana R Rath
Shoshana R Rath
SLSharon Lee
Sharon Lee
RKRishi S Kotecha
Rishi S Kotecha
MTMandy Taylor
Mandy Taylor
RJReimar C Junckerstorff
Reimar C Junckerstorff
CCCatherine Sy Choong
Catherine Sy Choong

28 June 2008 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
SRShoshana Rath
Shoshana Rath
NBNaor Bar‐Zeev
Naor Bar‐Zeev
KAKym Anderson
Kym Anderson
RFRosemary Fahy
Rosemary Fahy
RRRob Roseby
Rob Roseby

14 October 2014 in Endocrine Abstracts
Verified
Journal Article
Open access
LCLi Chan
Li Chan
TNTatiana Novoselova
Tatiana Novoselova
SRShoshana Rath
Shoshana Rath
KCKaren Carpenter
Karen Carpenter
NPNick Pachter
Nick Pachter
LMLou Metherell
Lou Metherell
Aberrant pseudoexon inclusion is rarely recognised as a cause of human disease. Here we report two novel, compound heterozygous mutations in nicotinamide nucleotide transhydrogenase (NNT), one of which activates a pseudoexon, as the cause of familial glucocorticoid deficiency in two siblings. Whole-exome sequencing identified a single novel, heterozygous variant (R71X) in both affected individuals. Follow-up cDNA analysis identified the pseudoexon inclusion (p.P998_D999ins23) and Sanger sequencing of genomic DNA identified a 4 bp duplication responsible for its’ activation. The variants segregated with the disease, R71X was inherited from the mother, P998_D999ins23 from the father and an unaffected sibling had inherited only the R71X variant. Neither variant has been annotated in any SNP or mutation databases and both will lead to premature truncation and presumably an inactive protein. The mutation resulting in pseudoexon inclusion could provide a potential target for antisense oligonucleotide therapy. Detection of such events in disease is hampered since introns, because of their frequently large size, are often excluded from mutational analyses, and it is often impossible/impractical to perform cDNA analysis.